| Symbol | Company | Weighting |
|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 3.82% |
| KRRO | KORRO BIO | 3.29% |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 3.13% |
| AXSM | AXSOME THERAPEUTICS INC. | 2.91% |
| OCS | OCULIS HOLDING AG | 2.59% |
| EWTX | EDGEWISE THERAPEUTICS | 2.48% |
| XENE | XENON PHARMACEUTICALS | 2.29% |
| TSHA | TAYSHA GENE THERAPIES I | 2.29% |
| MRK | MERCK & CO. NEW | 2.26% |
| TVTX | TRAVERE THERAPEUTICS INC | 2.22% |
| HUM | HUMANA INC | 2.19% |
| ALKS | ALKERMES INC | 2.18% |
| BMY | BRISTOL MYERS SQUIBB CO | 2.17% |
| URGN | UROGEN PHARMA LTD. | 2.08% |
| SNDX | SYNDAX PHARMACEUTICALS, INC. | 2.07% |
| ELV | ELEVANCE HEALTH INC | 2.00% |
| UNH | UNITEDHEALTH GROUP INC | 1.97% |
| EYPT | EYEPOINT INC | 1.92% |
| BRKR | BRUKER CORP | 1.88% |
| AVTX | AVALO THERAPEUTICS INC | 1.86% |
| DNLI | DENALI THERAPEUTICS INC. | 1.84% |
| IONS | IONIS PHARMACEUTICALS INC | 1.82% |
| RVTY | REVVITY INC | 1.79% |
| AZN | ASTRAZENECA PLC | 1.77% |
| SPRY | ARS PHARMACEUTICALS | 1.66% |
| PCVX | VAXCYTE INC | 1.66% |
| DYN | DYNE THERAPEUTICS, INC. | 1.59% |
| WAT | WATERS CORP | 1.56% |
| IDYA | IDEAYA BIOSCIENCES, INC | 1.56% |
| LLY | ELI LILLY CORP | 1.54% |
| ABBV | ABBVIE INC | 1.54% |
| MCK | MCKESSON CORP | 1.53% |
| NEO | NEOGENOMICS INC | 1.53% |
| GEHC | GE HEALTHCARE TECHNOLOGIES INC | 1.52% |
| THC | TENET HEALTHCARE CORP | 1.51% |
| VCEL | VERICEL CORP | 1.50% |
| ALC | ALCON INC | 1.50% |
| SNY | SANOFI- AVENTIS- ADR | 1.46% |
| SYK | STRYKER CORP | 1.44% |
| ARQT | ARCUTIS BIOTHERAPEUTICS | 1.43% |
| MDT | MEDTRONIC PLC | 1.41% |
| HCA | HCA HOLDINGS INC | 1.38% |
| TNDM | TANDEM DIABETES CARE INC | 1.38% |
| TMO | THERMO FISHER SCIENTIFIC INC | 1.34% |
| DHR | DANAHER CORP | 1.32% |
| ISRG | INTUITIVE SURGICAL INC | 1.31% |
| FULC | FULCRUM THERAPEUTICS, INC. | 1.30% |
| RGEN | REPLIGEN CORP | 1.30% |
| IRON | DISC MEDICINE INC | 1.27% |
| ICLR | ICON PLC | 1.26% |
| PRQR | PROQR THERAPEUTICS NV | 1.24% |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 1.22% |
| ZTS | ZOETIS INC | 1.17% |
| ABT | ABBOTT LABORATORIES | 1.16% |
| BSX | BOSTON SCIENTIFIC | 0.95% |
| JANX | JANUX THERAPEUTICS INC | 0.85% |
| PODD | INSULET CORP | 0.79% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Private Investments, LLC, Guggenheim Investments Loan Advisors, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2026 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.